Company profile · Heidelberg, Germany

Hummingbird Diagnostics

Molecular Diagnostics, miRNA Biomarkers, Liquid Biopsy, Oncology, and Neurology · Diagnostics platform

Hummingbird Diagnostics runs biomarker diagnostics development, liquid-biopsy programs, and molecular testing platform work in Heidelberg, Germany.

Lead
Tillman Weiss (verified ↗)
Address
Im Neuenheimer Feld 583, 69120 Heidelberg, Germany (source ↗)
Compliance
Not yet on record
Last reviewed
22 Mar 2026 (2mo ago)
Scale
Diagnostics platform
Capabilities
Biomarker Diagnostics Development · Liquid-Biopsy Programs · Molecular Testing Platform Work
Founded
2008
Headcount
11-50
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Tillman Weiss

Chief Executive Officer

Check official leadership source
Full addressIm Neuenheimer Feld 583, 69120 Heidelberg, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Hummingbird Diagnostics materials listing the Heidelberg address.

Open source
Operating profile

Diagnostics platform

Heidelberg, Germany. Molecular Diagnostics, miRNA Biomarkers, Liquid Biopsy, Oncology, and Neurology. Review completed on 22 Mar 2026.

2026 technical specializationMolecular Diagnostics, miRNA Biomarkers, Liquid Biopsy, Oncology, and Neurology
Core capabilities
Biomarker Diagnostics DevelopmentLiquid-Biopsy ProgramsMolecular Testing Platform Work
Governance

German molecular-diagnostics oversight

Official leadership disclosure, Official Heidelberg address disclosure, Diagnostics platform claim

Editorial note

Molecular Diagnostics, miRNA Biomarkers, Liquid Biopsy, Oncology, and Neurology

Hummingbird Diagnostics is published because official company materials confirm current leadership, Heidelberg operating address, and a real molecular-diagnostics platform.

Editorial note

Hummingbird Diagnostics is published because official company materials confirm current leadership, Heidelberg operating address, and a real molecular-diagnostics platform.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 22 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Biomarker Diagnostics Development
Liquid-Biopsy Programs
Molecular Testing Platform Work
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceOfficial Hummingbird Diagnostics materials naming Tillman Weiss as CEO.Source origin: hummingbird-diagnostics.comOpen source
Supporting evidenceOfficial Hummingbird Diagnostics materials confirming the Heidelberg address.Source origin: hummingbird-diagnostics.comOpen source
Physical-site evidenceOfficial Hummingbird Diagnostics materials listing the Heidelberg address.Source origin: hummingbird-diagnostics.comOpen source
Infrastructure

Declared infrastructure

Biomarker-analysis workflow
Molecular diagnostics systems
Clinical assay development infrastructure
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Hummingbird Diagnostics located?
Hummingbird Diagnostics operates from Im Neuenheimer Feld 583, 69120 Heidelberg, Germany, Heidelberg, Germany.
Who runs Hummingbird Diagnostics?
Hummingbird Diagnostics is led by Tillman Weiss, Chief Executive Officer. Verified 22 Mar 2026.
What does Hummingbird Diagnostics do?
Hummingbird Diagnostics runs biomarker diagnostics development, liquid-biopsy programs, and molecular testing platform work in Heidelberg, Germany. Core capabilities: Biomarker Diagnostics Development, Liquid-Biopsy Programs, Molecular Testing Platform Work.
Editorial context

Related technical briefs

Briefs that name Heidelberg as a covered market or city.